Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hypertension complex.

M Mendlowitz

    American Heart Journal
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    This study explores the complex factors behind hypertensive disease development and treatment. It addresses unsolved hypertension problems and discusses drug therapies based on underlying mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.

    Journal of medicinal chemistry·2003
    Same author

    Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding.

    Peptides·2002
    Same author

    Intimal tissue factor activity is released from the arterial wall after injury.

    Thrombosis and haemostasis·2000
    Same author

    Nucleolar localization of BRCA1 protein in human breast cancer.

    International journal of oncology·1998
    Same author

    Tissue factor in the pathogenesis of atherosclerosis.

    Thrombosis and haemostasis·1997
    Same author

    Hypertension: a personal odyssey.

    The Mount Sinai journal of medicine, New York·1996
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Nephrology
    • Pharmacology

    Background:

    • Hypertensive disease involves intricate etiological and developmental factors.
    • Numerous aspects of hypertension remain incompletely understood.
    • Understanding these complexities is crucial for effective therapeutic strategies.

    Purpose of the Study:

    • To discuss the multifaceted factors contributing to hypertensive disease.
    • To address key unresolved questions in the field of hypertension.
    • To examine current hypertension treatments, particularly pharmacotherapy, in relation to underlying mechanisms.

    Main Methods:

    • Review and discussion of existing literature on hypertension.
    • Identification and exploration of complex etiological factors.

    Related Experiment Videos

  • Analysis of current therapeutic approaches in hypertension management.

    • Main Results:

    • The genesis and progression of hypertensive disease are influenced by a complex interplay of factors.
    • Several critical questions regarding hypertension pathogenesis and progression remain unanswered.
    • Drug treatments for hypertension are being refined based on a deeper understanding of its mechanisms.

    Conclusions:

    • A comprehensive understanding of hypertension's complex mechanisms is essential for advancing treatment.
    • Further research is needed to resolve outstanding questions in hypertension.
    • Pharmacological interventions for hypertension should be guided by mechanistic insights.